Dr. Steven Edward Mapula, MD

Dr. Mapula practices at Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dr. Mapula's NPI, 1861623704, was assigned on July 27, 2009. Dr. Mapula graduated from Saint Louis University School Of Medicine in 2009. Dr. Mapula holds Texas license P7804.

Dr. Mapula's primary practice is Baylor University Medical Center, at 3500 Gaston Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-8082.

Dr. Mapula's primary practice is Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health. Dr. Mapula is also affiliated with Texas Health Fort Worth. The medical group on file is Acclaim Health. Dmand AI also links Dr. Mapula to 1 more hospital, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mapula practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Mapula's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Mapula is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Mapula is licensed in Texas.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Mapula treats.

CMS data shows 11 Medicare services from Dr. Mapula across 1 procedure code in 2023, all of them office visits, for 36 Medicare patients. Medicare paid $1,371 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Dr. Mapula in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mapula's median patient age at 57, with 88% women.

In 2024, Dr. Mapula wrote 219 Medicare Part D claims for 50 patients. 99% of them were for generic drugs. CMS names the drug for 156 of them, across 5 drugs with 11 or more claims each, at $3,613 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Mapula for performance year 2024, reported as part of a group. Dr. Mapula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of mastectomy by Dr. Mapula, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Mapula, published from 2015 to 2016. Dr. Mapula has published most often in Plast Reconstr Surg. Dr. Mapula's most frequent co-authors are Ronald E. Hoxworth, MD, Ronnie A. Pezeshk, MD and Benson Pulikkottil, MD.

CMS Open Payments shows 199 general payments to Dr. Mapula from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Abbvie Inc. paid the most, $5,831.

Dr. Mapula graduated from Saint Louis University School Of Medicine in 2009.

Dr. Mapula is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.